Classified in: Covid-19 virusSubjects: POLITICS,
ARTS/ENTERTAINMENT,
MISCELLANEOUS,
MISCELLANEOUS
MEDIA ADVISORY: TVO Today Live panel - "Can democracy survive the collapse of media?"
Toronto, ON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Media are invited to attend a TVO Today Live event featuring a moderated panel discussion on an important issue: "Can democracy survive the collapse of the media?"
PANEL GUESTS:
- Paul Rivett, Chief Executive Officer and co-owner of Torstar
- Jay Rosen, Associate Professor of Journalism at New York University and author of the blog PressThink
- The Honourable Pamela Wallin, Senator, former broadcast journalist and diplomat
- Farah Nasser, Global News National anchor
- Moderator: Steve Paikin, the host of TVO's flagship current affairs program, The Agenda with Steve Paikin
This TVO Today Live conversation will follow a free public screening of the new TVO Original Viral News. The documentary is a thrilling look at the daunting challenges faced by The Toronto Star's journalists and new owners during the Omicron wave of the COVID-19 pandemic. It premieres on TVO on Sunday, November 20, 2022, at 9 pm ET and will begin streaming on November 18 via TVO Today, YouTube, the TVO Today mobile app and smart TV services.
Members of the public can register to attend this event via Eventbrite.
DATE: Thursday, November 17, 2022
TIME: 7 pm ET
LOCATION: Isabel Bader Theatre, 93 Charles Street, Toronto, ON M5S 2C7
AGENDA: Doors open at 6:30 pm. Viral News screening begins at 7 pm with panel to follow.
MEDIA CONTACT: Sean Minogue, TVO. sminogue@tvo.org
This is the third in a series of TVO Today Live events on the future of democracy, made possible through the support of the Wilson Foundation, whose mission is to strengthen and enrich Canada in education leadership, community, history and heritage, and public service.
Learn more about TVO Original Viral News in this press release.
- 30 -
ABOUT TVO
TVO inspires learning that changes lives and enriches communities. Founded in 1970, we are a globally recognized digital learning organization that engages Ontarians of all ages with inclusive experiences and diverse perspectives. Through video, audio, games, courses, newsletters and articles, we're investing in the transformative potential of education for everyone. Funded primarily by the Province of Ontario, TVO is a registered charity supported by thousands of sponsors and donors. For more information, visit TVO.me, TVO.org and TVOkids.com.
Stream TVO on your favourite device.
Sign up to receive TVO media releases by email.
Social:
Twitter: @TVODocs
Facebook: @TVODocs
YouTube: /TVO
These press releases may also interest you
at 22:30 |
|
|
The "Research Antibodies and Reagents Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the...
|
at 22:15 |
|
|
The "Healthcare E-Commerce Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market.
The...
|
at 22:00 |
|
|
The "Smart Wearables Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market.
The global...
|
at 22:00 |
|
|
The bacterial disease diagnostics market size is forecast to grow by USD 3,766.05 million between 2022 and 2027. However, the growth momentum will be decelerating at a CAGR of 6.28% during the forecast period. The growth of the market is driven by...
|
at 21:45 |
|
|
The "Global Glass Packaging Market Size, Segments, Outlook and Revenue Forecast 2022-2028 by Glass Type, Capacity, Application, Geography" report has been added to ResearchAndMarkets.com's offering.
The Global Glass Packaging Market is expected to...
|
at 20:35 |
|
|
Biogen Inc. announced today the outcome of the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee meeting on tofersen, an investigational product for the treatment of superoxide dismutase 1...
|
|
|
|
News published on 10 november 2022 at 11:25 and distributed by: